バイオ医薬品の研究開発DX
Genedataは、世界中のバイオファーマ企業やバイオテクノロジー企業における研究・開発・製造プロセスを自動化・デジタル化し、革新的な医薬品の創出を加速する、業界No.1エンタープライズソフトウェアソリューションを開発・提供しています。
Our Customers
Genedataは1997年の創業以来、バイオ医薬品の研究開発におけるイノベーションを後押ししてきました。"Genedata Biopharma Platform"は、研究開発プロセスをデジタル化し、スループットとデータ品質を向上することで、研究開発ワークフロー全体を効率化します。
One Data Model
A single, unified data model powering collaboration and innovation
Science-Native
Developed by scientists for scientists, in collaboration with industry leaders
Automation & AI
Automated workflows and embedded AI turning data into intelligence
Proven Solution
Trusted for 25+ years by leading biopharma innovators worldwide
Off-the-Shelf
Ready-to-use and fast to deploy on-premises or SaaS
User Friendly
Complex workflows and stringent standards made easy and intuitive
Future-Proof
Open, scalable, and built on modern technology with compliance at its core
Maximum ROI
Highest value realization, year-over-year, reported by our customers
Automation & AI. Biopharma Reimagined.
Automation and AI are key to driving innovation, increasing efficiency, reducing costs and mitigating risk. They are not optional anymore. Genedata has a deep understanding of the complex biopharma R&D workflows, the data, and how it’s used across modalities. We are combining our expertise with a unified, structured data foundation, advanced automation technology and embedded AI to empower our customers to accelerate data workflows, increase scientific productivity, uncover hidden insights and enable scientific breakthrough.
Delivered. On Time. Compliant.
Biopharma companies cannot afford wasting their time to achieve operational efficiency and minimize time to patient . This is why we deliver the solutions they need, and we deliver them on time, always. And our customers have to minimize compliance and quality risks to comply with regulations and to deliver medicines of high quality, safety and efficacy to their patients. This is why we provide a platform with data integrity, traceability, and compliance, built-in by design.
Genmab + Genedata、Bio-IT Awardを受賞
Genmab社との共同開発プロジェクト「Accelerating chromatography workflows by redesigning and harmonizing data processing and reporting」が、Bio-IT World 2025 Innovative Practices Awardを受賞しました！
本プロジェクトから、クロマトグラフィーデータの管理・解析を効率化する、ベンダー非依存でユニークなエンタープライズソフトウェアプラットフォーム「Genedata Chromatics®」が誕生しました。複数の装置やアッセイから得たデータを統合・構造化することで、複数の実験間の二次解析を効率化するとともに、AI/ML活用の基盤を構築します。
Genedata Partner Symposium 2025
第11回 Genedata Partner Symposiumより、イベントレポートをお届けします。
今回、250名を超える研究者やITのプロフェッショナルに参加いただきました。出席企業には、AstraZeneca・Gilead・Novartis・Sanofi・Moderna・Pfizer・AbbVie・Novo Nordisk, Biogen・Astellas・J&J・Amgen・Daiichi Sankyo・Takeda・Boehringer Ingelheim・GSKが含まれます。
Expert-Led. Insight-Driven.
Stay ahead with practical insights from leading voices in biopharma at Genedata Webinar Week, a recurring multi-day virtual event. Across expert-led sessions, industry leaders share real-world strategies, applied use cases, and guidance on the technologies transforming modern R&D.
We undertook a thorough selection process to find the best antibody workflow platform and Genedata was the obvious choice.
One of the reasons we chose Genedata was the platform’s process coverage. We required that the full diversity of Pfizer’s large-molecule processes and technologies be supported by one integrated system.
We needed a central platform to capture and process data across our global R&D teams, while ensuring full data integrity and traceability, and Genedata was the only solution that ticked all the boxes right from the start.
